Capnography for monitoring end-tidal CO2 in hospital and pre-hospital settings: A health technology assessment M Richardson, K Moulton, D Rabb, S Kindopp, T Pishe, C Yan, I Akpinar, ... | 24 | 2016 |
Single-use medical devices: economic issues P Jacobs, I Akpinar Heart Asia 10 (2), 2018 | 14 | 2018 |
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS HD Akpinar I ,Jacobs P International Journal of Technology Assessment in Health Care 31 (1-2), 86-89, 2015 | 11 | 2015 |
Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics NX Thanh, I Akpinar, J Gratrix, S Plitt, P Smyczek, R Read, P Jacobs, ... International journal of STD & AIDS 28 (13), 1311-1324, 2017 | 8 | 2017 |
The costs of industry-sponsored drug trials in Canada DT Tran, I Akpinar, P Jacobs PharmacoEconomics-Open 4, 353-359, 2020 | 6 | 2020 |
Forecasting pharmaceutical prices for economic evaluations when there is no market: a review I Akpinar, P Jacobs, TD Tran PharmacoEconomics-Open 1, 65-68, 2017 | 6 | 2017 |
The economic contribution of industry-sponsored pharmaceutical clinical trials DT Tran, I Akpinar, R Fedorak, E Jonsson, J Mackey, L Richer, P Jacobs Journal of Pharmacy & Pharmaceutical Sciences 20, 407-414, 2017 | 4 | 2017 |
Cost analysis of a transition care bundle compared with usual care for COPD patients being discharged from hospital: evaluation of a randomized controlled trial C Yan, J Round, I Akpinar, CE Atwood, L Deuchar, M Bhutani, R Leigh, ... PharmacoEconomics-Open 7 (3), 493-505, 2023 | 3 | 2023 |
The costs of industry-sponsored medical device clinical trials in Alberta I Akpinar, A Ohinmaa, L Thording, DT Tran, RN Fedorak, L Richer, ... PharmacoEconomics-Open 3, 591-597, 2019 | 3 | 2019 |
Temporal trends of pharmacologic therapies for patients with chronic obstructive pulmonary disease in Alberta, Canada DT Tran, I Akpinar, I Mayers, T Makhinova, P Jacobs International Journal of Chronic Obstructive Pulmonary Disease, 2245-2256, 2019 | 3 | 2019 |
A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness, and cost-effectiveness of private cataract and orthopedic surgery clinics I Akpinar, E Kirwin, L Tjosvold, D Chojecki, J Round International Journal of Technology Assessment in Health Care 39 (1), e47, 2023 | 1 | 2023 |
Publicly funded clinical research in Canada I Akpinar, DT Tran, P Jacobs Healthcare Management Forum 32 (6), 323-325, 2019 | 1 | 2019 |
Sağlık Teknolojisi Değerlendirme Raporlarında Güvenilirlik ve Şeffaflık I AKPINAR Acıbadem Unıversıtesı Saglık Bılımlerı Dergısı 6 (3), 130-133, 2015 | 1 | 2015 |
Epimorphin expression in a rat model of pulmonary hypoplasia associated with congenital diaphragmatic hernia. Akpinar İ, Korgun D, Çetin A, Yesilkaya A, Karaguzel G, Boneval C Pediatr Surg Int. 30 (10), 1037-43, 2014 | 1 | 2014 |
Costs of industry-sponsored medical device trials in Canada I Akpinar PharmacoEconomics & Outcomes News 828, 10-18, 2019 | | 2019 |
Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review TD Tran, I Akpinar, P Jacobs | | 2017 |
THE ECONOMIC CONTRIBUTION OF PHARMACEUTICAL CLINICAL TRIALS TO HEALTH CARE AND HEALTH RESEARCH IN ALBERTA, CANADA DT Tran, I Akpinar, P Jacobs, E Jonsson, R Fedorak, L Richer VALUE IN HEALTH 20 (5), A32-A33, 2017 | | 2017 |
Authors’ Reply to Holko:“Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review” I Akpinar, P Jacobs, DT Tran PharmacoEconomics-Open 1, 71-71, 2017 | | 2017 |
Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and … D Chojecki, B Guo, C Yan, I Akpinar, A Waye, M El Shayeb, A Chuck, ... | | 2016 |
Newborn blood spot screening for galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and … A Waye, M El Shayeb, B Guo, A Chuck, I Akpinar, D Chojecki, C Yan, ... | | 2016 |